Multidrug resistance protein 4 (MRP4/ABCC4) is overexpressed in clear cell renal cell carcinoma (ccRCC) and is

Related Experiment Video

Updated: Dec 18, 2025

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

34.0K

Juan Pablo Melana Colavita1, Juan Santiago Todaro1, Maximiliano de Sousa2

  • 1Laboratorio de Investigaciones Bioquímicas de la Facultad de Medicina (LIBIM), Instituto de Química Básica y Aplicada del NEA, (IQUIBA NEA-UNNE-CONICET), Facultad de Medicina, Universidad Nacional del Nordeste, 3400 Corrientes, Argentina.

International Journal of Biological Macromolecules
|June 20, 2020
PubMed

Insights

This study reveals that MRP4 is overexpressed in clear cell renal cell carcinoma (ccRCC). Inhibiting this transporter disrupts cell metabolism and induces apoptosis, suggesting MRP4 as a potential therapeutic target for kidney cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Kidney cancer, particularly clear cell renal cell carcinoma (ccRCC), has a significant global incidence and mortality rate.
  • Current treatments like tyrosine kinase inhibitors and immunotherapy have limited impact on ccRCC mortality.
  • MRP4, an efflux pump, is implicated in the progression of various cancers.

Purpose of the Study:

  • To investigate the role of MRP4 in clear cell renal cell carcinoma (ccRCC).
  • To determine if MRP4 is a potential therapeutic target for ccRCC.

Main Methods:

  • Quantitative analysis of MRP4 expression in ccRCC tumors versus normal renal tissues.
  • Pharmacological inhibition of MRP4 in ccRCC cell culture models.
  • Assessment of cellular and metabolic changes following MRP4 inhibition, including cAMP metabolism, cell cycle, lipid composition, and apoptosis.

Main Results:

  • MRP4 is significantly overexpressed in ccRCC tumors compared to healthy kidney tissue.
  • Pharmacological inhibition of MRP4 in ccRCC cells led to disrupted cAMP metabolism.
  • Inhibition also caused cell cycle arrest, altered lipid profiles, increased cytoplasmic lipid droplets, and induced apoptosis.

Conclusions:

  • MRP4 is demonstrably overexpressed in ccRCC.
  • Targeting MRP4 pharmacologically impacts critical cellular processes in ccRCC.
  • These findings support the evaluation of MRP4 as a novel therapeutic target for ccRCC.
Keywords:
LipidomicsMRP4Renal carcinomacAMP

More Related Videos

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp111:02

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1

Published on: May 27, 2016

8.4K
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.2K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K